Maintaining Innovation and Safe Technologies Act

Proposed 2024-06-25 | Official source

Summary

Directs the Secretary of Health and Human Services to issue guidance by January 1, 2026, on Medicare payment requirements for remote monitoring devices with AI components that transmit health data for patient management and treatment.

  • This summary is awaiting validation (peer review by a second AGORA editor).

Key facts

🏛️ This document was proposed and/or enacted by the United States Congress but is now defunct. For authoritative text and metadata, visit the official source.

🎯 This document primarily applies to the government, rather than the private sector.

📜 This document's name is Maintaining Innovation and Safe Technologies Act.

Themes AI risks, applications, governance strategies, and other themes addressed in AGORA documents.
  • Thematic tags for this document are awaiting validation (peer review by a second AGORA editor).

Full text

  • This is an unofficial copy. The document has been archived and reformatted in plaintext for AGORA. Footnotes, tables, and similar material may be omitted. For the official text, visit the original source.
  • Thematic tags for this document are awaiting validation (peer review by a second AGORA editor).
A BILL To direct the Secretary of Health and Human Services to issue guidance on payment under the Medicare program for certain items involving artificial intelligence. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,
SECTION 1. Short title. This Act may be cited as the “Maintaining Innovation and Safe Technologies Act”. SEC. 2. Guidance on Medicare payment for certain items involving artificial intelligence. Not later than January 1, 2026, the Secretary of Health and Human Services shall use existing communications mechanisms to issue guidance on requirements for payment under part B of title XVIII of the Social Security Act (42 U.S.C. 1395j et seq.) for remote monitoring devices, such as continuous glucose monitors, that— (1) use an artificial intelligence component (such as a continuous adjustment component); and (2) transmit information to a health care provider for purposes of management and treatment of an individual.